Pharmaceutical

This foreign pharmaceutical Client was launching a new drug in the US. They had no awareness in the US and very stiff competition from well–known US pharmaceutical companies. RSML was charged with Introducing and building awareness of  the new Crohn’s Disease and Ulcerative Colitis drug to HCPs and Patients and to drive HCP website leads.

HCP – Implement a full-funnel integrated media strategy and plan to drive qualified and targeted awareness of the drug amongst HCP targets with the core brand story and messaging, expand through targeting high propensity HCPs with branded campaigns to shift to this drug as a potential solution for their patients. Promote engagement with the tactics and help HCPs understand brand value and unment needs in ulcerative Colitis and Crohn’s Disease. Optimize media toward lead generation and leverage PLD to guide the sales force.  
 
Patient – Implement a full-funnel integrated media strategy and plan to increase relevancy and action throughout the patient journey. Strategically used first, second and third party data to find patient prospects and actively move them from awareness to asking their physicians about the drug by reaching patients on platforms where they are actively discussing their disease with patients, caregivers, and the community. Served messaging and CTAs relevant to where the patients were likely to be in their learning journey along with strategic sequencing that drove them to the next stage in the funnel. 

The campaign drove a ROAS of 8.65